NCT02640755View on ClinicalTrials.gov

Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

January 28, 2016

Primary Completion Date

December 21, 2016

Study Completion Date

July 6, 2017

Conditions
Solid Malignancies
Interventions
DRUG

[14C]AZD2014

Radiolabelled dual TORC1/TORC2 inhibitor

DRUG

Multiple dose AZD2014

Dual TORC1/TORC2 inhibitor

DRUG

Fulvestrant

Hormonal Agent

DRUG

Paclitaxel

Taxane

Trial Locations (1)

M20 4BX

Research Site, Manchester

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

AstraZeneca

INDUSTRY

NCT02640755 - Absorption, Metabolism, Excretion and Pharmacokinetics of a Single Dose [14C]AZD2014 Followed by a Multiple Dose Phase | Biotech Hunter | Biotech Hunter